Profile data is unavailable for this security.
About the company
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
- Revenue in CAD (TTM)-12.09k
- Net income in CAD-2.31m
- Incorporated2006
- Employees--
- LocationSirona Biochem Corpc/o WeWork, 595 Burrard St.VANCOUVER V7X 1L4CanadaCAN
- Phone+1 (604) 641-4466
- Fax+1 (604) 608-5471
- Websitehttps://www.sironabiochem.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medicure Inc | 20.93m | -2.63m | 10.54m | 25.00 | -- | 0.5394 | -- | 0.5036 | -0.2529 | -0.2529 | 1.94 | 1.87 | 0.7288 | 2.28 | 4.38 | 837,280.00 | -9.16 | -13.42 | -12.73 | -18.28 | 61.41 | 61.87 | -12.56 | -27.38 | 1.42 | -- | 0.0202 | -- | -5.94 | -5.71 | -167.55 | -- | -28.82 | -- |
| Numinus Wellness Inc | 20.10m | -24.36m | 11.28m | -- | -- | 2.42 | -- | 0.5612 | -0.0906 | -0.0946 | 0.0752 | 0.0145 | 0.8572 | -- | 11.72 | -- | -103.89 | -77.31 | -129.39 | -84.20 | 30.80 | -- | -121.19 | -323.32 | -- | -13.08 | 0.6044 | -- | 256.95 | -- | 32.59 | -- | -- | -- |
| Telo Genomics Corp | 0.00 | -2.97m | 11.56m | 8.00 | -- | 18.44 | -- | -- | -0.0434 | -0.0434 | 0.00 | 0.0084 | 0.00 | -- | -- | 0.00 | -323.36 | -85.03 | -407.98 | -113.86 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -33.66 | -- | 24.41 | -- |
| Briacell Therapeutics Corp | 0.00 | -8.13m | 15.39m | 11.00 | -- | -- | -- | -- | -0.5306 | -0.5306 | 0.00 | -0.5060 | 0.00 | -- | -- | 0.00 | -33.97 | -59.37 | -43.50 | -63.11 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 24.35 | -- | -- | -- |
| Resverlogix Corp | 0.00 | -14.56m | 17.92m | 18.00 | -- | -- | -- | -- | -0.0559 | -0.0559 | 0.00 | -0.3802 | 0.00 | -- | -- | 0.00 | -138.80 | -- | -- | -- | -- | -- | -- | -- | 0.0459 | -0.8227 | -- | -- | -- | -- | -363.74 | -- | -- | -- |
| Sirona Biochem Corp | -12.09k | -2.31m | 19.41m | -- | -- | -- | -- | -- | -0.0091 | -0.0091 | -0.00005 | -0.012 | -0.0114 | -- | 0.5203 | -- | -218.11 | -173.09 | -- | -383.49 | -- | -- | -- | -1,405.28 | -- | -8.11 | -- | -- | -94.82 | -51.37 | 28.52 | -- | -- | -- |
| COSCIENS Biopharma Inc | 6.13m | -17.09m | 20.48m | 21.00 | -- | 0.4771 | -- | 3.34 | -12.68 | -12.68 | 3.62 | 11.61 | 0.0936 | 1.74 | 6.35 | -- | -26.11 | -26.24 | -30.53 | -30.34 | 39.42 | 83.68 | -278.95 | -300.31 | 3.05 | -- | 0.0604 | -- | -20.25 | -30.06 | 27.17 | -- | 16.12 | -- |
